FDA Clearance Tracker · K173875
GENFlex2 Total Knee System - Ultra-Congruent CR Tibial Insert
Last checked: Nov 20, 2026Latest source record: Jan 19, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jan 19, 2018
Substantially Equivalent
Time to decision
29 days
Received Dec 21, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K173875
- Device name
- GENFlex2 Total Knee System - Ultra-Congruent CR Tibial Insert
- Applicant
- Stelkast, Inc.
- Applicant location
- Mcmurray, PA
- Received
- Dec 21, 2017
- Decided
- Jan 19, 2018
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH)
- Device class
- Class II
- Regulation
- 21 CFR 888.3560
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JWH. The earliest in FDA's data is K760200, decided Jul 20, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K173875
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Stelkast, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Provident II Hip Stem510(k)
K190276 · Decided Mar 8, 2019 · 28 days after receipt
Device type: Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented (LPH) · Orthopedic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.